Aripiprazole and Genotropin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Aripiprazole (aripiprazole) and Genotropin (somatropin recombinant). Common drug interactions include weight increased among females and dehydroepiandrosterone increased among males.

The phase IV clinical study analyzes what interactions people have when they take Aripiprazole and Genotropin. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Aripiprazole?

Aripiprazole has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 39,143 Aripiprazole users. Check the latest studies of Aripiprazole.

What is Genotropin?

Genotropin has active ingredients of somatropin recombinant. It is often used in growth hormone deficiency. eHealthMe is studying from 41,924 Genotropin users. Check the latest studies of Genotropin.

On Jul, 26, 2026

20 people who take Aripiprazole and Genotropin together, and have interactions are studied.

Aripiprazole and Genotropin drug interactions.

What are the common drug interactions of Aripiprazole and Genotropin, by gender? *:

female:

Weight increased
Alopecia (absence of hair from areas of the body)
Ankle fracture
Aphonia (inability to produce voice)
Arthralgia (joint pain)
Back disorder
Blood cholesterol increased
Blood triglycerides increased
Blue toe syndrome (blue toe syndrome is a lack of blood flow to the toes causing a blue discoloration)
Bone pain

male:

Dehydroepiandrosterone increased
Drug ineffective
Sepsis (a severe blood infection that can lead to organ failure and death)
Injection site pain
Overdose
Suicide attempt
Injection site extravasation (flow of (blood or lymph) from injection site)
Dysphagia (a condition in which swallowing is difficult or painful)
Oral disorder (mouth disease)
Pharyngeal mass

What are the common drug interactions of Aripiprazole and Genotropin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Death
Sepsis (a severe blood infection that can lead to organ failure and death)

10-19:

Dehydroepiandrosterone increased
Drug ineffective
Injection site extravasation (flow of (blood or lymph) from injection site)
Dysphagia (a condition in which swallowing is difficult or painful)
Oral disorder (mouth disease)
Pharyngeal mass
Pharyngeal oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal)
Bone density increased
Insulin-like growth factor increased
Anaemia (lack of blood)

20-29:

n/a

30-39:

n/a

40-49:

Alopecia (absence of hair from areas of the body)
Ankle fracture
Decreased activity
Dizziness
Drug screen positive
Dysphagia (a condition in which swallowing is difficult or painful)
Dysphonia (speech disorder attributable to a disorder of phonation)
Face injury
Fall
Fatigue (feeling of tiredness)

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

Hypersensitivity: 13 people, 65.00%
Itching: 7 people, 35.00%
Stress And Anxiety: 5 people, 25.00%
Weakness: 4 people, 20.00%
Oppositional Defiant Disorder (a childhood disorder described by the diagnostic and statistical manual of mental disorders): 4 people, 20.00%
Epinephrine Increased: 4 people, 20.00%
Infection: 4 people, 20.00%
Chronic Fatigue Syndrome (disorder that causes extreme fatigue): 4 people, 20.00%
Muscle Spasms (muscle contraction): 4 people, 20.00%
Pain: 4 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Aripiprazole and Genotropin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously